Turf War Exposes Big Pharma's Dark Side as Bayer Sues Vaccine Makers** In a shocking twist in the battle for pharmaceutical profits, Bayer has launched lawsuits against giants P ...

Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...

The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical ...

News of Health Hoglund joining Sisvel and the Delhi High Court staying a $2.2 million decree in favour of Philips were also ...

The U.S. stock market closed mixed Thursday, with the S&P 500 edging up less than 0.1% to end nearly flat, the Dow Jones Industrial Average DJIA climbing 0.6% and the tech-heavy Nasdaq Composite COMP ...

In the latest trading session, Moderna (MRNA) closed at $33.86, marking a -5.66% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%. Meanwhile, the Dow ...

Groups have also requested records about the work of coronavirus researcher Ralph Baric. A court ruled UNC doesn’t have to turn them all over.

The Trump administration’s unprecedented decision to slash the number of recommended vaccines for children opens the door to ...

Bayer has opened a new legal front in the long-running battles over COVID-19 vaccine technology, suing several major ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey ...

Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...

The futures are trading flat on Wednesday after a second strong day for Wall Street, as the Dow Jones Industrial Average hit ...